Catatan bukti metode

Phase III clinical trial

A Phase III clinical trial is a large-scale, confirmatory randomised controlled trial designed to establish the efficacy and safety of an intervention in the target patient population before regulatory submission. It builds on the signal identified in Phase II, tests the intervention at its proposed dose under controlled conditions, and provides the primary evidence base for marketing authorisation or guideline adoption.

Sources recorded, not reviewed

Catatan sumber

Kutipan disalin apa adanya dari catatan sumber metode. Tidak ada verifikasi tingkat klaim yang disimpulkan darinya.

Phase III Confirmatory Clinical Trial

Catatan metode taksonomi · process-pipeline / epidemiology

Friedman, L. M., Furberg, C. D., DeMets, D. L., Reboussin, D. M., & Granger, C. B. (2015). Fundamentals of Clinical Trials (5th ed.). Springer. · ISBN 978-3319185385
International Council for Harmonisation (ICH). (1997). E8 General Considerations for Clinical Trials. ICH Harmonised Guideline. · URL

Buka metode lengkap

Klaim yang dikurasi

Klaim tersimpan dalam buku besar bukti, masing-masing dengan penilaiannya sendiri.

Belum ada klaim yang dikurasi

Tampilan ini tidak menciptakan penilaian klaim ketika buku besar tidak memilikinya.

Metode terkait

Dihasilkan dari grafik metode dan ditampilkan sebagai relasi yang disarankan mesin — tidak ada klaim bukti yang disimpulkan.

Taxonomic bucketAdaptive Randomized Clinical Trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketCohort Studymachine-suggested · Relational suggestion, not evidence.Taxonomic bucketMulticenter Randomized Clinical Trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketPhase II clinical trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketPhase IV studymachine-suggested · Relational suggestion, not evidence.Taxonomic bucketRandomized clinical trialmachine-suggested · Relational suggestion, not evidence.